Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies
Shihui Yua,
Guoxin Tana,
Dandan Liub,
Xinggang Yang*a and
Weisan Pan*a
aDepartment of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China. E-mail: pppwwwsss@163.com; yangxg123@163.com
bSchool of Biomedical & Chemical Engineering, Liaoning Institute of Science and Technology, Benxi 117004, PR China
First published on 18th April 2017
Abstract
Correction for ‘Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies’ by Shihui Yu et al., RSC Adv., 2017, 7, 16668–16677.
In the original manuscript, the email address of the corresponding author Xinggang Yang was omitted. The email address has been added to the affiliation information of this manuscript.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |